Page 1 of Clinical Trials for Eisai Inc. [SPONSOR-COLLABORATORS], 391 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: October 28, 2011
Condition(s): Alzheimer's Disease
2
Completed
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: April 25, 2010
Condition(s): Alzheimer's Disease
3
Completed
Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver
Last Updated: January 28, 2010
Condition(s): Lesions of the Liver
4
Completed
E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer
Last Updated: March 19, 2012
Condition(s): Breast Cancer
5
Completed
Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism
Last Updated: January 27, 2010
Condition(s): Pulmonary Embolism
6
Completed
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease
Last Updated: September 6, 2011
Condition(s): Non-erosive Gastroesophageal Reflux Disease
7
Completed
Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
Last Updated: September 22, 2009
Condition(s): Attention Impairment
8
Completed
An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy
Last Updated: April 24, 2010
Condition(s): Diabetic Neuropathy
9
Completed
A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
Last Updated: April 16, 2012
Condition(s): Breast Cancer
10
Completed
Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures
Last Updated: April 24, 2010
Condition(s): Epilepsy
11
Completed
Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial
Last Updated: September 5, 2008
Condition(s): Muscle Spasm; Back Pain
12
Completed
Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
Last Updated: February 24, 2011
Condition(s): High Blood Pressure
13
Completed
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
Last Updated: May 2, 2012
Condition(s): Vascular Dementia
14
Completed
ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs
Last Updated: March 10, 2010
Condition(s): Epilepsy
15
Recruiting
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
Last Updated: April 4, 2012
Condition(s): Advanced or Metastatic Solid Tumors; Previously Untreated Gastric Cancer
16
Recruiting
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
Last Updated: April 4, 2012
Condition(s): Hepatocellular Carcinoma
17
Recruiting
A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments
Last Updated: May 18, 2012
Condition(s): Non-Small Cell Lung Cancer
18
Active, not recruiting
Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer
Last Updated: April 4, 2012
Condition(s): Non Small Cell Lung Cancer
19
Recruiting
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Last Updated: May 18, 2012
Condition(s): Colon Cancer and Rectal Cancer
20
Suspended
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer
Last Updated: April 4, 2012
Condition(s): Bladder Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Eisai+Inc.

Page 1 of Clinical Trials for Eisai Inc. [SPONSOR-COLLABORATORS], 391 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About